Nonin Medical Releases Special Report on Competitive Advantages of Using Quality Pulse Oximeters at Medtrade 2012
Report Highlights How Pulse Oximeter Performance Can Affect Results, Revenue and Reputation for Durable Medical Equipment Providers
Nonin Medical, Inc., the inventor of finger pulse oximeters and a leader in noninvasive medical monitoring, today released a Pulse Oximetry Special Report for durable medical equipment (DME) providers at Booth #953 at Medtrade 2012 in Atlanta. Medtrade is the largest home medical equipment tradeshow in the United States.
The report, "Too Good to be True? Three Ways Cheap Pulse Oximeters May be Short-changing Your Patients and Profits," is designed to help DME home respiratory monitoring providers understand that not all pulse oximeters perform alike, quality does matter, and reliable product performance can provide a competitive advantage. The results of the report are based on clinical data findings, customer feedback and competitive comparison testing collected by Nonin Medical over 26 years.
"With the influx of imported pulse oximeters into the homecare market, and the belief that all pulse oximeters perform alike, it’s reasonable for DME providers to think that they are getting the best value from cheap or free oximeters,” said Bill Wood, Homecare Key Accounts Manager, Nonin Medical. "However, our pulse oximeter customers have found that when they have opted for these types of oximeters, in many cases, they often ended up paying a hidden price in terms of missed revenue opportunities, lost productivity, continuous inventory replacement, and patient dissatisfaction due to broken or malfunctioning pulse oximeters.
“This hidden price can seriously erode a DME’s bottom line and affect future revenues, not to mention compromise patient safety and outcomes,” Wood said. The answer, he added, lies in understanding product performance differences and knowing what to look for in pulse oximeters for home use — tips outlined in Nonin’s DME Pulse Oximetry Special Report.
Nonin’s Special Report provides a comprehensive checklist and clinical resources that DMEs can use to evaluate pulse oximeters objectively before purchasing,” Wood said. “It may help DMEs avoid being penny wise and pound foolish in this cost-sensitive environment,” he said.
In addition to obtaining their free DME Pulse Oximetry Special Report, Medtrade 2012 attendees can see and try Nonin’s pulse oximeters, capnographs and sensors at Booth #953 at the Georgia World Congress Center, Tues. and Wed., Oct. 16 and 17, 10 a.m. to 5 p.m., and Thurs., Oct. 18th, 10 a.m. to 2 p.m.
Nonin Medical’s pulse oximeters, sensors and capnographs are U.S.-market-approved prescription medical devices that provide industry-leading accuracy, consistency and reliability in the most challenging conditions. Nonin oximeters are made of hazardous-free material in the United States. In addition, accuracy and performance claims for Nonin’s pulse oximeters are supported by published peer-reviewed, clinical studies.
For more information and to obtain a copy of Nonin’s DME Pulse Oximetry Special Report, Medtrade attendees can visit booth #953. Or they can download a copy of the report at nonin.com/homecare, under “DME Special Report.”
Nonin Medical, Inc. invented the finger pulse oximeter (the original Onyx® brand) and designs and manufactures noninvasive medical monitoring solutions that meet customers’ technology needs today and tomorrow. Headquartered in Plymouth, Minn., USA, with an additional customer service center in Amsterdam, the Netherlands, Nonin Medical sells its pulse and regional oximeters, capnographs, sensors and software to health professionals and consumers in more than 125 countries. The company has more than 300 OEM partners worldwide. For more information, visit nonin.com.